Collins Helen Louise - Insider Non-Derivative Transactions at Enliven Therapeutics, Inc. (ELVN) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Apr 11, 2024, Collins Helen Louise's relationship to Enliven Therapeutics, Inc. (ELVN) is Officer (CHIEF MEDICAL OFFICER), and currently has 20,000 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other ELVN insiders.
Data Source: SEC.
Collins Helen Louise - Insider Non-Derivative Transactions at ELVN
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Apr 12, 2024 | Sell -- (Common Stock) | 20000 | 25.07 | 0 |
| Apr 12, 2024 | M -- (Common Stock) | 20000 | 2.48 | 20000 |